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Interactions Between Infections/Inflammation
and Risk Factors in Coronary Artery Disease
I read with interest the report by Mehta et al. (1) that relates coronary
artery disease, and thus ischemic heart disease (IHD), to interactions
between traditional risk factors and infections and inflammation.
Although Mehta et al. suggested it is unlikely that a common patho-
genetic process can explain atherosclerosis, a hypothesis I recently
proposed, the altered homeostatic (AH) theory (2) provides a unitary
way to explain atherosclerosis and IHD.
The AH theory is based on the spasm of resistance vessel (S-RV)
concept of ischemic diseases (which asserts that S-RV directly induces
symptoms in ischemic diseases as IHD) (3,4), and on a literature
review (5) designed to provide more evidence for the S-RV concept.
The findings of the literature review (5) seemed extraordinary.
Major and diverse risk factors for IHD express the combination of a
tendency toward S-RV and thromboses (S-RV/clotting); risk factors
were abnormal lipids, homocysteine, emotional stress, smoking, circa-
dian rhythm, chemotherapy, cold exposure, cocaine, diabetes and
obesity.
Also, multiple and diverse factors that ameliorate IHD express
vasodilation of resistance vessels (V-RV) and an antithrombotic
tendency (V-RV/anticlotting); ameliorating factors were vasodilators,
fish oils, magnesium, the exercised state, estrogens, aspirin and vita-
mins. Further, the set of risk and ameliorating factors for IHD, with
few exceptions, also operates in hypertension, stroke, migraine and
Raynaud’s disease, and a separate literature review (2) showed that
many of these risk and ameliorating factors are known to operate in
atherosclerosis.
The expression of S-RV/clotting by multiple risk factors for multi-
ple disorders suggested that risk factors might operate through com-
mon mechanisms to induce a variety of diseases, and altered ho-
meostasis seemed a reasonable way to explain these findings. The AH
theory was developed through a series of steps, and important to the
theory’s development was the findings that multiple ameliorating
factors express V-RV/anticlotting and thus act opposite of risk factors
that express S-RV/clotting.
In brief, the AH theory asserts that risk factors favor atheroscle-
rosis, IHD, and other disorders by “inappropriately” shifting ho-
meostasis towards defensive action (fight/flight) and thus favoring
S-RV/clotting and disease; factors that ameliorate IHD shift ho-
meostasis toward rest (conservation/withdrawal) and foster V-RV/
anticlotting and disease improvement. The S-RV/clotting can act
either directly to induce disease or act as markers for other mecha-
nisms of altered homeostasis. Inflammation is a major defense mech-
anism and, in keeping with Mehta et al. (1), probably plays a significant
role in atherosclerosis.
Of interest, the scheme proposed by Mehta et al. (1) for athero-
sclerosis includes multiple factors that were implicated by the AH
theory in altered homeostasis (2). Of special significance to the AH
theory, Mehta et al. listed spasm and thromboses; they also included
inflammation, infection, dyslipidemia, homocysteine excess, folate
deficiency, nitric oxide inactivation and free radicals.
The AH theory, if valid, has major therapeutic implications for
preventing IHD. Instead of the primary goal of cholesterol-lowering,
the primary goal would be reducing the expression of S-RV/clotting by
multiple risk factors; this would include cholesterol-lowering, as cho-
lesterol expresses S-RV/clotting.
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Reply
I thank Dr. Hellstrom for his comments on our review. I strongly
believe that it is unlikely that a single risk factor or a combination of
four or five risk factors explains a disease process (coronary athero-
sclerosis) that affects a majority of the world population. The proposed
scheme for a role of infection in atherosclerosis in our review was
designed to explain atherogenesis in a select group of genetically
susceptible individuals. Whereas traditional risk factors may explain
the development of atherosclerosis in a significant minority of patients
with coronary artery disease (CAD), in others different factors, such as
homocyteinemia or primary altered homeostasis, may be the culprit. I
believe that the evidence for vasospasm as a primary or major
causative factor in CAD is lacking, although it is quite likely that
vasospasm is a result of altered endothelial and smooth muscle
function secondary to some metabolic or neurohormonal alteration.
An important role for altered activity of autonomic nervous system is
plausible in inducing vasoconstriction (spasm) and in the precipitation
of plaque rupture as a basis of acute coronary syndromes, as suggested
by Hellstrom (his reference 2).
In view of multiple etiologies of coronary atherosclerosis, I suggest
that attempts be made to identify and treat causative factor(s) leading
to atherosclerosis in the individual patient, rather than using a
“shot-gun” approach of use of cholesterol lowering drugs, antiplatelet
and antithrombotic agents, beta-blocking agents and angiotensin-
converting enzyme inhibitors in all patients. Current therapeutic
approaches, including surgical procedures, may represent a “band-aid”
or “patch” approach to treat an underlying problem that may vary from
individual to individual.
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